The Expert Consensus on the Whole Processing Management of Concurrent Chemoradiotherapy for Chinese Esophageal Cancer
Infectious Cancer Professional Committee of China Anti-Cancer Association
Esophageal Cancer Committee of China Anti-Cancer Association
Chinese and Western Medicine Integrated Esophageal Cancer Committee of China Anti-Cancer Association
Integrative Rehabilitation Committee of Esophageal Cancer of China Anti-Cancer Association
Abstract：Esophageal cancer is the fourth most lethal tumor in China,accounting for about half of the world's new cases and deaths each year,of which esophageal squamous cell carcinoma accounts for more than 90％,with a 5-year survival rate of 29.6％.With the advancement of radiotherapy technology and optimization of chemotherapy regimen,concurrent chemoradiotherapy has made breakthrough progress which has pushed the overall treatment situation of esophageal cancer to a fundamental change.Several international guidelines recommend neoadjuvant concurrent chemoradiotherapy plus surgery or definitive concurrent chemoradiotherapy as a side-by-side choice for locally advanced esophageal cancer,which provides a theoretical basis for the"organ preservation"concept for patients with locally resectable esophageal cancer.It provides theoretical basis and new ideas for the concept of"organ preservation"for patients with locally resectable esophageal cancer.In order to better guide the whole processing management of concurrent chemoradiotherapy for esophageal cancer,the Infectious Cancer Committee,Chinese and Western Medicine Integrated Esophageal Cancer Committee and Esophageal Cancer Integrative Rehabilitation Committee of the China Anti-Cancer Association have organized domestic experts in related fields,and after several rounds of in-depth discussions and modifications,systematically sorted out the latest domestic and international guidelines and evidence-based medical evidence,and fully considered the specific conditions of clinical practice in China,to form the present expert consensus.
Keywords：esophageal squamous cell carcinomaconcurrent chemoradiotherapywhole processing managementexpert consensus
Publication Date：2024-06-30
Online Publishing Date：2026-09-12(First online date of this platform, not the publication date of the document)
Pages：14( 81-94 )